Related Experiment Video
Updated: Jul 8, 2025

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
Acquisition of suppressive function by conventional T cells limits antitumor immunity upon Treg depletion
Sarah K Whiteside1, Francis M Grant2, Giorgia Alvisi3
1Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK.
Abstract:
Regulatory T (Treg) cells contribute to immune homeostasis but suppress immune responses to cancer. Strategies to disrupt Treg cell-mediated cancer immunosuppression have been met with limited clinical success, but the underlying mechanisms for treatment failure are poorly understood. By modeling Treg cell-targeted immunotherapy in mice, we find that CD4+ Foxp3- conventional T (Tconv) cells acquire suppressive function upon depletion of Foxp3+ Treg cells, limiting therapeutic efficacy. Foxp3- Tconv cells within tumors adopt a Treg cell-like transcriptional profile upon ablation of Treg cells and acquire the ability to suppress T cell activation and proliferation ex vivo. Suppressive activity is enriched among CD4+ Tconv cells marked by expression of C-C motif receptor 8 (CCR8), which are found in mouse and human tumors. Upon Treg cell depletion, CCR8+ Tconv cells undergo systemic and intratumoral activation and expansion, and mediate IL-10-dependent suppression of antitumor immunity. Consequently, conditional deletion of Il10 within T cells augments antitumor immunity upon Treg cell depletion in mice, and antibody blockade of IL-10 signaling synergizes with Treg cell depletion to overcome treatment resistance. These findings reveal a secondary layer of immunosuppression by Tconv cells released upon therapeutic Treg cell depletion and suggest that broader consideration of suppressive function within the T cell lineage is required for development of effective Treg cell-targeted therapies.
Insights
Depleting regulatory T (Treg) cells to fight cancer can backfire. Conventional T (Tconv) cells gain suppressive abilities, hindering therapy. Targeting IL-10 signaling alongside Treg depletion may improve cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Biology
- Immunotherapy
Background:
- Regulatory T (Treg) cells maintain immune homeostasis but suppress anti-cancer immune responses.
- Current Treg cell-targeted cancer immunotherapies show limited success due to poorly understood resistance mechanisms.
Purpose of the Study:
- To investigate the mechanisms underlying therapeutic failure in Treg cell-targeted cancer immunotherapy.
- To identify alternative immunosuppressive pathways activated upon Treg cell depletion.
Main Methods:
- Mouse models of Treg cell-targeted immunotherapy.
- Analysis of T cell populations, gene expression (transcriptional profiling), and suppressive function ex vivo.
- Assessment of IL-10's role in immunosuppression and therapeutic efficacy.
- In vivo studies involving conditional gene deletion (Il10) and antibody blockade of IL-10 signaling.
Main Results:
- Depletion of Treg cells induced suppressive function in CD4+ Foxp3- conventional T (Tconv) cells.
- Tumor-infiltrating Foxp3- Tconv cells adopted a Treg-like transcriptional profile and suppressed T cell activity.
- CD4+ Tconv cells expressing C-C motif receptor 8 (CCR8) were identified as a key suppressive population in tumors.
- CCR8+ Tconv cells expanded systemically and intratumorally upon Treg cell depletion, mediating IL-10-dependent immunosuppression.
- Conditional deletion of IL-10 in T cells or IL-10 signaling blockade synergized with Treg cell depletion to enhance anti-tumor immunity.
Conclusions:
- Conventional T cells can acquire immunosuppressive functions upon Treg cell depletion, representing a novel mechanism of therapeutic resistance.
- CCR8+ Tconv cells are a critical mediator of this secondary immunosuppression.
- Targeting IL-10 signaling in conjunction with Treg cell depletion offers a promising strategy to overcome treatment resistance in cancer immunotherapy.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

